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ingle stroke at least 12 months previously, with recovery of Indoor walking
nd home return. Fatigue was assessed by a multidimensional scale, the MFI-
0 which allowed determining the fatigue level in its four dimensions (general
atigue, mental fatigue, reduced activity and lack of motivation). We examined
ossible associations between the level of fatigue in each of its dimensions and
ifferent parameters related to the patient (age, sex, body mass index), to the brain
njury (etiology, side, duration), and to other stroke complications (motor deficit,
isability level, anxiety, depression, sleep disturbance and pain). Disability was
etermined by the Barthel Index score. Anxiety and depression were assessed
y the HAD scale.
esults.– The different domains of fatigue identified by the MFI-20 were present
t equivalent levels in the patients without predominance of one domain over
he others. “General fatigue” and “mental fatigue” were strongly correlated with
nxiety and depression. “Lack of motivation” was correlated with sleep dis-
urbance (P = 0.047) and with depression (P = 0.047). “Reduced activity” was
orrelated with anxiety (P = 0.02). On the other hand, there were no significant
orrelations of the different domains of fatigue with the other parameters studied.
onclusion.– Post-stroke fatigue is multidimensional. Some comorbidities
depression, anxiety, sleep disorders) that are accessible to treatment are asso-
iated with a higher risk of fatigue in each of its dimensions.
oi:10.1016/j.rehab.2011.07.344
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bjective.– Evaluation of walking speed (10-m walking test) in patients with
hronic hemiparesis after at least 3 consecutive botulinum neurotoxin injections
hile patients follow a guided self-rehabilitation contract.
esign.– Open label trial.
etting.– Outpatient rehabilitation center.
atients.– Fourteen patients with chronic hemiparesis (mean 52 months post-
troke) consecutively treated with at least 3 BTX injections, while following a
uided self-rehabilitation contract.
ntervention.– Guided Self-Rehabilitation Contract involving prolonged daily
tretching postures and exercises of rapid alternating movements of maximal
mplitude, in combination with 3 consecutive injections of botulinum neuro-
oxin (onabotulinumtoxin A, abobotulinumtoxin A, incobotulinumtoxin A or
imabotulinumtoxin B) in selected lower limb muscles (plantar flexors, rectus
emoris) during a 9-month period.
ain outcome measures.– Comfortable and maximal barefoot 10 m walking
peed was assessed 6 times during a 9-month period (mean pre-post injection
elay 40 days; mean post/pre-assessment delay 71 days). A multivariable ana-
ysis was performed to test the effects of Visit and status pre/post-injection as
redictors of walking speed variations.
esults.– Overall, comfortable barefoot walking speed increased by 49 ± 14%
mean ± SEM, P < 0.001) in the 9-month period, while maximal barefoot wal-
ing speed increased by 65 ± 13% (mean ± SEM, P < 0.001). While the first
njection improved comfortable walking speed by 9.9% (P = 0.019) and maxi-
al walking speed by 16.5% (P < 0.001), this injection-induced effect waned in
ubsequent injections. Overall, the factor Visit (passage of time) was a predictor
f walking speed variations (P < 0,001) while the status pre/post injection was
predictor only for the maximal speed. At baseline, maximal walking speed
as a predictor of subsequent walking speed variations (comfortable, P = 0.024;
aximal, P = 0.006), unlike comfortable walking speed.
onclusion.– Against common knowledge [1], stroke patients may meaningfully
mprove walking speed in chronic stages once BTX injections are associated with
n appropriate neurorehabilitation program, such as a guided self-rehabilitation
ontract.
–
P
c
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1] Green J, Forster A, Bogle S, Young J. Physiotherapy for patients with mobility
roblems more than 1 year after stroke: a randomised controlled trial. Lancet
002;359(9302):199–203.
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bjective.– The aim of the present research is dual-fold: first, to provide a better
nderstanding of perception of action by stroke patients; second, to gain more
nsight about which kinematic cues are relevant for action recognition in virtual
isplays.
ethod.– To do so, naive stroke patients and an aged matched healthy control
roup had to assess the level of attainment of pointing movements displayed on
computer screen. Two different kinematic displays were used: a stick diagram
nd a dot end-point representation. The displayed movements were from patients
ith very severe, severe, moderate and mild hemiparesis, or healthy subjects.
esults.– It was shown that stroke patients were able to distinguish between
ealthy and several attained movement trajectories by observation of minimal
inematic displays, although with a larger variability than controls. Subse-
uently, patients succeeded better in doing so when observing an end-point
ot representation. It was assumed that the observation of the end-point trajec-
ory directed their attention to the strongest affordances: smoothness, indicated
y the number of velocity peaks, and form of the trajectory, indicated by the
urvature index.
iscussion.– These findings should be taken into account when implementing
vatars in virtual reality (e.g., constructing serious games) for upper-extremity
troke rehabilitation, in order to make sure that the moving avatars provide
either too little, nor too much information to the attained observer.
oi:10.1016/j.rehab.2011.07.346
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atients.– Suffering from multiple sclerosis (MS) resort to a coping strategy
eeply modifying their general perceived Quality of life (QoL). Coping and QoL
ssessments are essential to implement appropriate behavorial cognitive therapy
rogrammes. However, the currently validated Coping with Health Injuries and
roblems (CHIP) scale has poor reliability in MS Context.
bjective.– To validate a short and specific coping scale Two-Lives Scale: TLS
oping 10:
easy to use and easy to score in routine medical practice;
to bring out the link between the respective coping and QoL scores.
atients and methods.– We conducted a multicenter cross-sectional study of 521
onsecutive MS patients. We used the CHIP, MOS-SF36 scales and TLS coping
cale.
